Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 6
2004 7
2005 3
2006 1
2007 2
2008 3
2009 6
2010 9
2011 8
2012 8
2013 11
2014 16
2015 10
2016 12
2017 9
2018 16
2019 9
2020 16
2021 32
2022 23
2023 17
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Results by year

Filters applied: . Clear all
Page 1
Extracellular vesicles as human therapeutics: A scoping review of the literature.
Fusco C, De Rosa G, Spatocco I, Vitiello E, Procaccini C, Frigè C, Pellegrini V, La Grotta R, Furlan R, Matarese G, Prattichizzo F, de Candia P. Fusco C, et al. Among authors: furlan r. J Extracell Vesicles. 2024 May;13(5):e12433. doi: 10.1002/jev2.12433. J Extracell Vesicles. 2024. PMID: 38738585 Free PMC article. Review.
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients.
Dolcetti E, Buttari F, Bruno A, Azzolini F, Gilio L, Di Caprio V, Lauritano G, Borrelli A, Galifi G, Furlan R, Finardi A, Musella A, Guadalupi L, Mandolesi G, Rovella V, Centonze D, Stampanoni Bassi M. Dolcetti E, et al. Among authors: furlan r. Front Neurol. 2024 Feb 23;15:1326506. doi: 10.3389/fneur.2024.1326506. eCollection 2024. Front Neurol. 2024. PMID: 38585351 Free PMC article.
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation.
Stampanoni Bassi M, Gilio L, Galifi G, Buttari F, Dolcetti E, Bruno A, Belli L, Modugno N, Furlan R, Finardi A, Mandolesi G, Musella A, Centonze D, Olivola E. Stampanoni Bassi M, et al. Among authors: furlan r. Parkinsonism Relat Disord. 2024 May;122:106071. doi: 10.1016/j.parkreldis.2024.106071. Epub 2024 Feb 28. Parkinsonism Relat Disord. 2024. PMID: 38432021 Free article.
Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers.
Poletti S, Zanardi R, Mandelli A, Aggio V, Finardi A, Lorenzi C, Borsellino G, Carminati M, Manfredi E, Tomasi E, Spadini S, Colombo C, Drexhage HA, Furlan R, Benedetti F. Poletti S, et al. Among authors: furlan r. Brain Behav Immun. 2024 May;118:52-68. doi: 10.1016/j.bbi.2024.02.019. Epub 2024 Feb 15. Brain Behav Immun. 2024. PMID: 38367846 Free article. Clinical Trial.
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis.
Ulutekin C, Galli E, Schreiner B, Khademi M, Callegari I, Piehl F, Sanderson N, Kirschenbaum D, Mundt S, Filippi M, Furlan R, Olsson T, Derfuss T, Ingelfinger F, Becher B. Ulutekin C, et al. Among authors: furlan r. Cell Rep Med. 2024 Jan 16;5(1):101351. doi: 10.1016/j.xcrm.2023.101351. Epub 2023 Dec 21. Cell Rep Med. 2024. PMID: 38134930 Free PMC article.
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
Fissolo N, Benkert P, Sastre-Garriga J, Mongay-Ochoa N, Vilaseca-Jolonch A, Llufriu S, Blanco Y, Hegen H, Berek K, Perez-Miralles F, Rejdak K, Villar LM, Monreal E, Alvarez-Lafuente R, Soylu OK, Abdelhak A, Bachhuber F, Tumani H, Martínez-Yélamos S, Sánchez-López AJ, García-Merino A, Gutiérrez L, Castillo-Trivino T, Lycke J, Rosenstein I, Furlan R, Filippi M, Téllez N, Ramió-Torrentà L, Lünemann JD, Wiendl H, Eichau S, Khalil M, Kuhle J, Montalban X, Comabella M. Fissolo N, et al. Among authors: furlan r. J Neurol Neurosurg Psychiatry. 2024 Apr 12;95(5):410-418. doi: 10.1136/jnnp-2023-332251. J Neurol Neurosurg Psychiatry. 2024. PMID: 37940409
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study.
Montini F, Nozzolillo A, Tedone N, Mistri D, Rancoita PM, Zanetta C, Mandelli A, Furlan R, Moiola L, Martinelli V, Rocca MA, Filippi M; Clinical SanRaf MS Study Group. Montini F, et al. Among authors: furlan r. J Neurol Neurosurg Psychiatry. 2024 Mar 13;95(4):342-347. doi: 10.1136/jnnp-2023-332073. J Neurol Neurosurg Psychiatry. 2024. PMID: 37857497
Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury.
Wilson D, Chan D, Chang L, Mathis R, Verberk I, Montalban X, Comabella M, Fissolo N, Bielekova B, Masvekar R, Chitnis T, Ziemssen T, Akgün K, Blennow K, Zetterberg H, Brück W, Giovannoni G, Gnanapavan S, Bittner S, Zipp F, Comi G, Furlan R, Lehmann S, Thebault S, Freedman M, Bar-Or A, Kramer M, Otto M, Halbgebauer S, Hrusovsky K, Plavina T, Khalil M, Piehl F, Wiendl H, Kappos L, Maceski A, Willemse E, Leppert D, Teunissen C, Kuhle J. Wilson D, et al. Among authors: furlan r. Clin Chem Lab Med. 2023 Sep 13;62(2):322-331. doi: 10.1515/cclm-2023-0518. Print 2024 Jan 26. Clin Chem Lab Med. 2023. PMID: 37702323
202 results